Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: A systematic review and meta-analysis

Thorax

Volumn 62, Issue 11, 2007, Pages 944-949

  Gosker, Harry R ^a,b   Zeegers, Maurice P ^c   Wouters, Emiel F M ^b   Schols, Annemie M W J ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SYSTEMATIC REVIEW; VASTUS LATERALIS MUSCLE;

BIOLOGICAL MARKERS; BODY MASS INDEX; CARBON MONOXIDE; FORCED EXPIRATORY VOLUME; HUMANS; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MYOSIN HEAVY CHAINS; OXYGEN; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES; VITAL CAPACITY;

EID: 34748831476     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.078980     Document Type: Review

References (38)

1. ATS/ERS. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999;159:S1-40.
2. Gosker HR, Engelen MPKJ, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9.
3. Gosker HR, Lencer NHMK, Franssen FME, et al. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003;123:1416-24.
4. Berry MJ, Rejeski WJ, Adair NE, et al. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999;160:1248-53.
5. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
6. Barreiro E, Gea J, Corominas JM, et al. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003;29:771-8.
7. Montes de Oca M, Torres SH, Gonzalez Y, et al. Changes in exercise tolerance, health related quality of life, and peripheral muscle characteristics of chronic obstructive pulmonary disease patients after 6 weeks' training. Arch Bronconeumol 2005;41:413-8.
8. Montes de Oca M, Torres SH, Gonzalez Y, et al. Peripheral muscle composition and health status in patients with COPD. Respir Med 2006;100:1800-6.
9. Gosker HR, Schrauwen P, Hesselink MKC, et al. Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD. Eur Respir J 2003;22:88-93.
10. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre type shifting and metabolic profile in patients with COPD. Eur Respir J 2002;19:617-26.
11. Doucet M, Debigare R, Joanisse DR, et al. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J 2004;24:971-9.
12. Engelen MP, Orozco-Levi M, Deutz NE, et al. Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease. Eur Respir J 2004;23:545-51.
13. Ramirez-Sarmiento A, Orozco-Levi M, Guell R, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 2002;166:1491-7.
14. 2 with small muscle mass exercise. Am J Respir Crit Care Med 2004;169:89-96.
15. Vogiatzis I, Terzis G, Nanas S, et al. Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest 2005;128:3838-45.
16. Satta A, Migliori GB, Spanevello A, et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997;10:2853-60.
17. Gosker HR, Schrauwen P, Broekhuizen R, et al. Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 2006;290:E976-81.
18. Koechlin C, Maltais F, Saey D, et al. Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 2005;60:834-41.
19. Jobin J, Maltais F, Doyon JF, et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 1998;18:432-7.
20. Hayot M, Michaud A, Koechlin C, et al. Skeletal muscle microbiopsy: a validation study of a minimally invasive technique. Eur Respir J 2005;25:431-40.
21. Allaire J, Maltais F, LeBlanc P, et al. Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve 2002;25:383-9.
22. Debigare R, Cote CH, Hould FS, et al. In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD. Eur Respir J 2003;21:273-8.
23. Allaire J, Maltais F, Doyon JF, et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 2004;59:673-8.
24. Russell AP, Somm E, Debigare R, et al. COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibers. J Cardiopulm Rehabil 2004;24:332-9.
25. Saey D, Michaud A, Couillard A, et al. Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:1109-15.
26. Hildebrand IL, Sylvén C, Esbjörnsson M, et al. Does chronic hypoxaemia induce transformations of fibre types? Acta Physiol Scand 1991;141:435-9.
27. Maltais F, Sullivan MJ, LeBlanc P, et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 1999;13:850-4.
28. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990;3:192-6.
29. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30:1467-74.
30. Fuld JP, Awede A, Neder JA, et al. Skeletal muscle histology and functional capacity in COPD patients (abstract). Eur Respir J 2002;20:289s.
31. Fournier M, Casaburi R, Storer T, et al. Cellular and molecular adaptations in skeletal muscle to testosterone and/or resistence training in men with COPD (abstract). Am Respir J Crit Care Med 2004;169:A904.
32. Casaburi R, Bhasin S, Cosentino L, et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:870-8.
33. Svartberg J, Aasebo U, Toft I, et al. Testosterone supplementation in men with COPD and muscle morphology (abstract). Eur Respir J 2005;26:659s.
34. Svartberg J, Aasebo U, Hjalmarsen A, et al. Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respir Med 2004;98:906-13.
35. Fabbri LM, Pauwels RA, Hurd SS, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary updated 2003. COPD 2003;2004:105- 41.
36. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
37. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
38. Toft I, Lindal S, Bonaa KH, et al. Quantitative measurement of muscle fiber composition in a normal population. Muscle Nerve 2003;28:101-8.